Bol Inf Farmacoter Navar. 2021;29(2):1-14
https://doi.org/10.54095/BITN20212902EN

Off-label use of gabapentinoids is not recommended due to the lack of consistent evidence available and its potential risks (sedation, dizziness or respiratory depression). Some recommendations are provided for a safe prescription of gabapentinoids

Authors:

- Natalia Alzueta. Medicines Advice and Information Service. Navarre Health Service

- Patricia García. Medicines Advice and Information Service. Navarre Health Service

-Irati Irigoyen. Servicio de Farmacia. Pharmacy Service of Complejo Hospitalario de Navarra. Navarre Health Service